Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;64(4):786-794.
doi: 10.1109/TBME.2016.2573642. Epub 2016 Jun 7.

An Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images

An Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images

Xin Chen et al. IEEE Trans Biomed Eng. 2017 Apr.

Abstract

Objective: We describe and evaluate an automated software tool for nerve-fiber detection and quantification in corneal confocal microscopy (CCM) images, combining sensitive nerve- fiber detection with morphological descriptors.

Method: We have evaluated the tool for quantification of Diabetic Sensorimotor Polyneuropathy (DSPN) using both new and previously published morphological features. The evaluation used 888 images from 176 subjects (84 controls and 92 patients with type 1 diabetes). The patient group was further subdivided into those with ( n = 63) and without ( n = 29) DSPN.

Results: We achieve improved nerve- fiber detection over previous results (91.7% sensitivity and specificity in identifying nerve-fiber pixels). Automatic quantification of nerve morphology shows a high correlation with previously reported, manually measured, features. Receiver Operating Characteristic (ROC) analysis of both manual and automatic measurement regimes resulted in similar results in distinguishing patients with DSPN from those without: AUC of about 0.77 and 72% sensitivity-specificity at the equal error rate point.

Conclusion: Automated quantification of corneal nerves in CCM images provides a sensitive tool for identification of DSPN. Its performance is equivalent to manual quantification, while improving speed and repeatability.

Significance: CCM is a novel in vivo imaging modality that has the potential to be a noninvasive and objective image biomarker for peripheral neuropathy. Automatic quantification of nerve morphology is a major step forward in the early diagnosis and assessment of progression, and, in particular, for use in clinical trials to establish therapeutic benefit in diabetic and other peripheral neuropathies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Original CCM image. (b) Manually quantified CCM image. (c) Automatically quantified CCM image. Red lines represent main nerve fibres, blue lines are branches and green spots indicate branch points on the main nerve trunks. Refer to online coloured version.
Fig. 2
Fig. 2
(a) Original CCM image (b) Response image after nerve-fibre detection and denoising (c) Nerve-fibre skeleton with highlighted weak connection segments (d) Nerve-fibre skeleton after assessment of weak connections. (e) Automatically detected end points (hollow circles) and intersection points (solid circles). (f) Final detected nerve fibres.
Fig. 3
Fig. 3
(a) Original CCM image with a highlighted segment, a selection of orthogonal profile lines are indicated on the enlarged inset. Profiles are calculated at each pixel along the segment. (b) Average of all the profile lines along the whole fibre segment. (c) The symmetric profile of (b) is firstly calculated, and then normalised (Solid line). A Gaussian distribution is fitted for nerve-fibre width estimation (broken line). The final width equals 2.5 times the RMS width (σ) of the fitted Gaussian curve.
Fig. 4
Fig. 4
ROC curves for nerve-fibre detection on dataset 2, using DMNN (Dual Model, Neural Network), DMRF (Dual Model, Random Forest), DTNN (Dual-Tree Wavelet, neural Network) and DTRF (Dual-Tree Wavelet, Random Forest) respectively.
Fig. 5
Fig. 5
Boxplots of manually measured features for control, non-neuropathy and neuropathy groups (a) MCNFD (b) MCNFL (c) MCNBD.
Fig. 6
Fig. 6
Boxplots of automatically measured features for control, non-neuropathy and neuropathy groups in dataset 2 (a) ACNFD (b) ACNFL (c) ACNBD (d) ACNFA (e) ASDOH (f) ASDWH.

References

    1. Boulton AJ. Management of Diabetic Peripheral Neuropathy. Clinical Diabetes. 2005;23(1):9–15.
    1. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabetic Medicine. 2004;21(9):976–982. - PubMed
    1. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, O’Brien PC, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A C. v. N. T. Investigators. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: CI vs. NPhys trial. Muscle Nerve. 2010;42(2):157–164. - PMC - PubMed
    1. Dyck PJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, Zafft AJ, Russell JW, Thomas K, Davies JL, Carter RE, Melton LJ, Litchy WJ C. v. N. T. Investigators. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle nerve. 2013;48(3):369–374. - PMC - PubMed
    1. Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, Bastyr EJ, Litchy WJ, O’Brien PC. Challenges in Design of Multicenter Trials: Endpoints Assessed Longitudinally for Change and Monotonicity. Diabetes Care. 2007;30:2619–2625. - PubMed

Publication types

MeSH terms